Diwa, Khalif M.

HRN: 27-84-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/01/2026
01/08/2026
IV
90 Mg
Q24hrs
Pcap C
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: